低剂量CT用于肺癌筛查的系统评价总体回顾

该数据集包含低剂量CT用于肺癌筛查的总体回顾,汇总14项荟萃分析证据,评估LDCT对肺癌诊断和死亡率的影响。

Taylor & FrancisTaylor & Francis
DataCite Commons
2025-08-12 更新
浏览 10
表格Lung cancerscreeninglow dose CTincidencemortalityrisk ratiosensitivityspecificity
An umbrella review of systematic evidence on the Low Dose Computed Tomography (LDCT) for lung cancer screening

基本信息

模态
表格
大小
0.009576659 GB
许可
CC BY 4.0
创建/更新时间
2025-08-12
版本
v1

资源简介

低剂量CT用于肺癌筛查的系统评价总体回顾

【一句话概览】

本数据集是 figshare 公开的结构化表格数据集,收录 2 个文件、合计 9.58 MB,主题涵盖 Lung cancer、screening、low dose CT、incidence、mortality,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《An umbrella review of systematic evidence on the Low Dose Computed Tomography (LDCT) for lung cancer screening》。配套论文《An umbrella review of systematic evidence on the Low Dose Computed Tomography (LDCT) for lung cancer screening》发表于 Future Oncology(2025),DOI:10.1080/14796694.2025.2531428。项目资助方:We would like to thank the Department of Health Research, Ministry of Health and Family Welfare, Government of India, for selecting ICMR-NCDIR as an HTA- Resource Hub and providing necessary financial assistance which support this research.。源站首次发布:2025-07-15。

【数据内容】

源站原始描述:Despite lung cancer’s high mortality rate, many countries still lack organized lung cancer screening programs. This review aims to evaluate the impact of low-dose computed tomography (LDCT) screening on lung cancer diagnosis, mortality, and overall clinical outcomes. Following the Joanna Briggs Institute methodology for umbrella reviews, a comprehensive search was conducted in PubMed, Embase, and the Cochrane Library for reviews published between January 2013 and December 2023. Eligible meta-ana…

【数据结构与技术规格】

文件数 2 个,合计 9.58 MB。ifon_a_2531428_sm7974.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,22.57 KB。数据集 DOI:10.6084/m9.figshare.29571965.v1。

【主题与分类】

源站学科分类:Medicine、Biotechnology、Cancer、Science Policy。主题标签:Lung cancer、screening、low dose CT、incidence、mortality、risk ratio、sensitivity、specificity。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://tandf.figshare.com/articles/dataset/An_umbrella_review_of_systematic_evidence_on_the_Low_Dose_Computed_Tomography_LDCT_for_lung_cancer_screening/29571965

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:An umbrella review of systematic evidence on the Low Dose Computed Tomography (LDCT) for lung cancer screening. Taylor & Francis. Mathew, Stany; Thangavel, Gowthaman; Pujar, Praveen; Pant, Apourv; Nath, Anita

【使用注意】

· 源站最后修改于 2025-08-12,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

免费样本无法满足模型训练要求?千方提供经三甲医院脱敏、带病理回证与专家标注的商业级专病数据集。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "ifon_a_2531428_sm7976.docx" "https://ndownloader.figshare.com/files/56286914"
curl -L -o "ifon_a_2531428_sm7974.docx" "https://ndownloader.figshare.com/files/56286917"

文件清单

  • ifon_a_2531428_sm7976.docx(9.55 MB)
  • ifon_a_2531428_sm7974.docx(22.57 KB)

文件总体积 9.58 MB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Despite lung cancer’s high mortality rate, many countries still lack organized lung cancer screening programs. This review aims to evaluate the impact of low-dose computed tomography (LDCT) screening on lung cancer diagnosis, mortality, and overall clinical outcomes.
Following the Joanna Briggs Institute methodology for umbrella reviews, a comprehensive search was conducted in PubMed, Embase, and the Cochrane Library for reviews published between January 2013 and December 2023. Eligible meta-analyses included studies comparing LDCT screening with chest X-ray (CXR) or no screening, reporting outcomes such as sensitivity, specificity, and lung cancer mortality. The methodological quality of the included reviews was assessed using AMSTAR-2.
Out of 801 citations, 14 meta-analyses met the inclusion criteria. LDCT demonstrated high sensitivity (0.97, 95% CI: 0.94–0.98) and specificity (0.87, 95% CI: 0.82–0.91). It significantly increased early-stage lung cancer detection (RR: 1.31, 95% CI: 1.18–1.45) and reduced lung cancer mortality by 18% (RR: 0.82, 95% CI: 0.75–0.90). However, the reduction in all-cause mortality (RR: 0.91, 95% CI: 0.75–1.06) was not statistically significant. Overdiagnosis and false positives remain essential challenges.
This umbrella review confirms that LDCT screening effectively reduces lung cancer mortality, particularly in high-risk populations.
Lung cancer was the most commonly diagnosed cancer worldwide in 2022, leading to over 2.5 million new cases and 1.8 million deaths. Although lung cancer has a high death rate, many countries still do not have screening programs in place to detect it early. This review examined the effectiveness of a special type of scan, known as low-dose computed tomography (LDCT), in detecting lung cancer early and saving lives. Researchers searched several major medical databases for studies published between 2013 and 2023. They focused on studies that compared LDCT scans with regular chest X-rays or no screening and checked the quality of the studies they included. Out of 801 studies found, 14 high-quality reviews were selected. The results showed that LDCT scans are very good at correctly detecting lung cance

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.29571965.v1(source: https://tandf.figshare.com/articles/dataset/An_umbrella_review_of_systematic_evidence_on_the_Low_Dose_Computed_Tomography_LDCT_for_lung_cancer_screening/29571965)。

需要用于商业化训练或医疗器械注册(NMPA/FDA)?

公开数据往往缺乏完整的病理回证与专家标注。千方医数集依托陕川双基地与超十家三甲医院直连,提供完全合规、去标识化、支持注册级质控的专病数据集交易服务。